Skip to main content
. 2020 Aug 10;53(9):e12887. doi: 10.1111/cpr.12887

Table 2.

Overview of Hippo signalling pathway induced lncRNAs in cancer development

LncRNA Tumour type Expression Interaction with Hippo cascade Biological function in cancers Ref.
BCAR4 BC YAP promotes BCAR4 expression Glycolysis 26
CYTOR (LINC00152) CRC YAP increases CYTOR expression, which in turn sponges to miR‐632 and miR‐185‐3p to target FSCN1 Proliferation, invasion, metastasis 51
H19 Osteosarcoma, bladder cancer YAP increases H19 expression Proliferation, migration 53, 90
MT1DP Liver cancer YAP and Runx2 inhibit MT1DP expression dependent on FoxA1 Proliferation, apoptosis, colony formation 47
NORAD Lung and breast cancer metastasis YAP/TAZ‐TEAD and NuRD complex repress NORAD expression Migration and invasion 52

Abbreviations: ↑ upregulated; ↓ downregulated; BC, breast cancer; BCAR4, breast cancer antiestrogen resistance 4; CRC, colorectal cancer; CYTOR, cytoskeleton regulator RNA; FSCN1, fascin actin‐binding protein 1; MT1DP, metallothionein 1D, pseudogene; NORAD, non‐coding RNA activated by DNA damage; TAZ, transcriptional co‐activator with PDZ‐binding motif; TEAD, transcriptional enhancer‐associated domain; YAP, yes‐associated protein.